Cardiff Oncology Ownership | Who Owns Cardiff Oncology?


OverviewForecastRevenueFinancialsChartTranscripts

Cardiff Oncology Ownership Summary


Cardiff Oncology is owned by 26.69% institutional investors, 6.60% insiders, and 66.71% retail investors. Blackrock is the largest institutional shareholder, holding 5.88% of CRDF shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.57% of its assets in Cardiff Oncology shares.

CRDF Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCardiff Oncology26.69%6.60%66.71%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock2.63M5.88%$5.84M
Vanguard group2.14M4.78%$4.74M
Assenagon asset management1.22M2.72%$2.70M
Geode capital management910.67K2.04%$2.02M
State street805.02K1.80%$1.79M
Mai capital management658.79K1.47%$1.46M
Morgan stanley513.22K1.15%$1.14M
Marshall wace, llp298.83K0.67%$663.40K
Millennium management239.61K0.54%$531.93K
Blair william & co/il227.63K0.51%$505.34K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Elkhorn partners limited partnership41.00K0.06%$91.00K
Avestar capital140.47K0.03%$311.84K
Findec wealth services16.00K0.02%$35.52K
Denver wealth management15.23K0.02%$33.82K
Xtx topco83.44K0.02%$185.23K
Mai capital management658.79K0.01%$1.46M
Callan capital65.05K0.01%$144.40K
Invst36.00K0.01%$73.80K
Thoroughbred financial services52.38K0.01%$116.00K
Assenagon asset management1.22M0.01%$2.70M

Top Buyers

HolderShares% AssetsChange
Blackrock2.63M0.00%1.95M
Assenagon asset management1.22M0.01%962.94K
State street805.02K0.00%665.08K
Geode capital management910.67K0.00%475.84K
Morgan stanley513.22K0.00%433.80K

Top Sellers

HolderShares% AssetsChange
Laurion capital management lp---928.72K
Millennium management239.61K0.00%-443.69K
Eam investors---161.90K
Ubs oconnor---150.00K
Marshall wace, llp298.83K0.00%-135.75K

New Positions

HolderShares% AssetsChangeValue
Avestar capital140.47K0.03%140.47K$311.84K
Nuveen asset management53.12K-53.12K$117.92K
Thoroughbred financial services52.38K0.01%52.38K$116.00K
Rhumbline advisers45.99K0.00%45.99K$102.10K
New york state common retirement fund43.00K0.00%43.00K$95.00K

Sold Out

HolderChange
Front row advisors-2.00
Newbridge financial services group-17.00
Macquarie group-1.37K
America first investment advisors-4.00K
Connor, clark & lunn investment management-10.11K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202488-8.33%12,508,364-2.23%263.25%34-45.16%23109.09%
Jun 30, 20249617.07%12,794,21952.97%288.17%6240.91%11-
Mar 31, 20248241.38%8,363,78057.97%1813.33%44214.29%11-21.43%
Dec 31, 202358-3.33%5,294,425-2.97%117.95%14-26.32%14-
Sep 30, 20236013.21%5,456,266-8.95%126.79%1911.76%1475.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.25M2.57%-
iShares Russell 2000 ETF956.64K2.06%-2.16K
Vanguard Institutional Extnd Mkt Idx Tr600.17K1.23%-
Fidelity Small Cap Index404.51K0.87%-1.37K
BIT Biotech Opportunities S295.52K0.63%-
Fidelity Extended Market Index250.16K0.54%4.11K
iShares Russell 2000 Value ETF234.44K0.50%-
State St Russell Sm/Mid Cp® Indx NL Cl C229.55K0.49%-8.10K
State St Russell Sm Cap® Indx SL Cl I191.10K0.41%-
Vanguard Russell 2000 ETF178.75K0.37%-1.12K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 12, 2024TANNENBAUM RENEE P-Buy$34.22K
Dec 11, 2024PACE GARY W-Buy$29.90K
Dec 11, 2024PACE GARY W-Buy$910.30K
Dec 19, 2023PACE GARY W-Buy$41.10K
Nov 10, 2023PACE GARY W-Buy$22.49K

Insider Transactions Trends


DateBuySell
2024 Q42-
2024 Q2--
2024 Q1--
2023 Q42-
2023 Q2--

CRDF Ownership FAQ


Who Owns Cardiff Oncology?

Cardiff Oncology shareholders are primarily institutional investors at 26.69%, followed by 6.60% insiders and 66.71% retail investors. The average institutional ownership in Cardiff Oncology's industry, Biotech Stocks , is 47.04%, which Cardiff Oncology falls below.

Who owns the most shares of Cardiff Oncology?

Cardiff Oncology’s largest shareholders are Blackrock (2.63M shares, 5.88%), Vanguard group (2.14M shares, 4.78%), and Assenagon asset management (1.22M shares, 2.72%). Together, they hold 13.39% of Cardiff Oncology’s total shares outstanding.

Does Blackrock own Cardiff Oncology?

Yes, BlackRock owns 5.88% of Cardiff Oncology, totaling 2.63M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 5.84M$. In the last quarter, BlackRock increased its holdings by 1.95M shares, a 287.98% change.

Who is Cardiff Oncology’s biggest shareholder by percentage of total assets invested?

Elkhorn partners limited partnership is Cardiff Oncology’s biggest shareholder by percentage of total assets invested, with 0.06% of its assets in 41K Cardiff Oncology shares, valued at 91K$.

Who is the top mutual fund holder of Cardiff Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cardiff Oncology shares, with 2.57% of its total shares outstanding invested in 1.25M Cardiff Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools